Carrick Therapeutics lands $35m investment from Pfizer

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 71%

Business News News

Business Business Latest News,Business Business Headlines

Dublin-based biopharma firm has received investment to support the rapid development of its flagship drug samuraciclib which is used in the treatment of HR+, HER2- breast cancer

Carrick Therapeutics, a Dublin-headquartered biopharma firm, has landed a $35 million investment from Pfizer as it also confirmed the final closure of a $25 million Series C funding round.

The company which is developing pioneering treatments to defeat some of the most aggressive cancers was founded by Elaine Sullivan, a former vice-president for research and development at both Eli Lilly and AstraZeneca, in 2016.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in BUSİNESS

Business Business Latest News, Business Business Headlines